Screening Colonoscopy FAQs (Billing & Coding Guide)

Screening colonoscopy is an important preventive test offered for colorectal cancer and precancerous polyps in patients who do not have symptoms. Accurate reporting and coding matter here because reimbursement, patient cost-sharing, and compliance requirements differ significantly between screening and diagnostic colonoscopy. Not slightly different. Significantly.

Under Medicare and most commercial insurance plans, specific CPT and HCPCS codes, along with appropriate modifiers, must be applied before correct claim processing and preventive benefit coverage kicks in. Missing one modifier changes the entire outcome for the patient and the practice.

Difference Between Screening and Diagnostic Colonoscopy

The difference between screening and diagnostic colonoscopy is, for the most part, a matter of intent and is directly linked to coding, insurance coverage, and cost sharing by the patient. Proper classification of the service is necessary for correct reimbursement and Medicare and commercial payer guidelines.

What's the difference between screening and diagnostic colonoscopy? 

Screening colonoscopy is performed on an individual who does not have signs/symptoms of colorectal disease. The intent is just prevention, early detection of colorectal cancer or polyps. If a polyp or cancer is found during the procedure, it is still considered screening because the purpose of the procedure was to prevent the discovery of cancer or polyp. 

A diagnostic colonoscopy is done when a patient has symptoms or other clinical abnormalities like diarrhea, abdominal pain or rectal bleeding or gastrointestinal issues. As the procedure is used for diagnosis or evaluation, and not prevention, it will usually fall under the standard cost-sharing structure, which includes any Medicare and most private insurance plan co-pay, deductible, or coinsurance.

Under the Affordable Care Act, preventive services with an A or B rating from the USPSTF are generally covered at 100% by Medicare and most commercial payers. No co-pay, no deductible, no coinsurance. But with that benefit comes a condition which is correct CPT and ICD-10-CM codes should be submitted to identify the service as screening. Miss that, and the preventive benefit does not apply.

Screening Colonoscopy Coding: CPT and HCPCS Reporting

Correctly coding colonoscopy for patients who opt for colonoscopy for CRC screening is critical for proper reimbursement, to ensure that preventive benefits are used appropriately, and to prevent patient billing mistakes. Coding is dependent on the payer type (commercial, Medicaid, Medicare) and if the procedure is only screening or if therapeutic intervention is associated (biopsy or polyp removal).

What is the right code for patients who choose colonoscopy for their CRC screening?

For commercial insurance and Medicaid patients who choose colonoscopy for their CRC screening, CPT code 45378 is used as the baseline code for a diagnostic colonoscopy performed as part of screening services. If additional procedures are performed during the colonoscopy, coding must reflect the specific intervention:

• 45380 – Colonoscopy with biopsy (single or multiple)
• 45384 – Colonoscopy with removal of lesion using hot biopsy forceps
• 45385 – Colonoscopy with polyp removal using snare technique
• 45388 – Colonoscopy with ablation of lesion

Appending Modifier 33 (Preventive Service) for these claims will signify that the procedure is performed in the screening process for colorectal cancer. Without this modifier, the service might be processed as a diagnostic service and the patient may have to pay a co-pay, deductible, or coinsurance.

For Medicare beneficiaries who choose colonoscopy for their CRC screening, HCPCS codes are used instead of CPT screening modifiers:

• G0121 – Screening colonoscopy for average-risk individuals
• G0105 – Screening colonoscopy for high-risk individuals

If a polyp or lesion is removed, the appropriate CPT code (45380, 45384, 45385, or 45388) should be reported along with Modifier PT, which indicates that a colorectal cancer screening test was converted into a diagnostic or therapeutic procedure.

Correct use of codes and modifiers is critical because missing or incorrect modifiers can lead to claim denials, incorrect patient financial responsibility, and loss of preventive coverage benefits.

Colonoscopy After Positive Non-Invasive CRC Screening Test: Coding & Modifiers

Correct coding and modifier application is critical when a patient receives a positive result from a non-invasive colorectal cancer (CRC) screening test, and subsequently undergoes a screening colonoscopy, to ensure claims are processed correctly and preventive service benefits are not lost under Medicare and commercial payer coding guidelines.

What is the right code to use when a patient needs a screening colonoscopy after a positive non-invasive CRC screening test?

For commercial insurance and Medicaid patients, when a colonoscopy is performed after a positive non-invasive CRC screening test, the appropriate colonoscopy CPT code (such as 45378 or 45380) should be reported based on the procedure performed. In these cases, Modifier 33 (Preventive Service) must be appended to indicate that the service is linked to a preventive screening pathway. This ensures the claim is processed under preventive benefit rules where applicable.

If a screening colonoscopy is performed after a positive finding from any approved stool-based screening test, the claim must include a HCPCS code of either G0105 or G0121 and the Modifier KX for Medicare beneficiaries (on or after 1/1/2023) to indicate that the criteria for coverage have been met.

These qualifying non-invasive CRC screening tests include:

• gFOBT (CPT 82270) – guaiac-based fecal occult blood test
• iFOBT / FIT (HCPCS G0328) – immunoassay-based fecal occult blood test
• Cologuard™ (CPT 81528) – multi-target stool DNA test

Failure to append Modifier KX to G0105 or G0121 in these scenarios will result in the Medicare claim being returned as unprocessable, requiring correction and resubmission.

If a polyp or lesion is removed during the colonoscopy, the appropriate CPT code (45380, 45384, 45385, or 45388) must be reported along with Modifier PT, indicating that a screening colonoscopy was converted into a diagnostic or therapeutic procedure.

It is also important to note that under current Medicare rules, when a polyp is removed during a screening colonoscopy, the beneficiary is responsible for 15% cost-sharing from 2023 to 2026, which reduces to 10% from 2027 to 2029, and will be fully covered at 100% starting in 2030. Many patients are unaware that full elimination of coinsurance is being phased in gradually.

G0105 Vs G0121 in Medicare Colonoscopy Screening

A key distinction between HCPCS codes G0105 and G0121 have to do with screening frequency and eligibility, and is crucial for reporting Medicare screening colonoscopy services accurately. 

What is the difference between G0105 and G0121?

Medicare differentiates screening colonoscopy codes based on whether a patient is considered high risk or average risk for colorectal cancer.

• G0121 (Average Risk Screening Colonoscopy)
• This code is used for Medicare beneficiaries who do not have high-risk factors for colorectal cancer. These patients are eligible for a screening colonoscopy once every 10 years. In such cases, the appropriate reporting also includes the diagnosis code V76.51 (Special screening for malignant neoplasm of the colon).
• G0105 (High-Risk Screening Colonoscopy)
• This code applies to Medicare beneficiaries classified as high risk for colorectal cancer. Eligibility for screening colonoscopy sits at once every 24 months, but with a condition clinical necessity must be documented and a supporting diagnosis code must back it up. Risk status cannot be assumed. It has to be established in the record before the claim goes out.

Who is considered high risk under Medicare guidelines?

A patient is classified as high risk for colorectal cancer if they have one or more of the following conditions:

• A close relative (parent, sibling, or child) with colorectal cancer or adenomatous polyps
• Family history of familial adenomatous polyposis (FAP)
• Family HNPCC, regardless of whether the patient has been tested
• Clinically important personal history of colorectal cancer
• Inflammatory bowel diseases (IBD) such as Crohn’s disease or ulcerative colitis

Correct identification of risk level is critical, as it determines not only the appropriate HCPCS code (G0105 vs G0121) but also the screening interval and payer acceptance of the claim.

How do I bill for a patient seen prior to a screening colonoscopy with no GI symptoms and who is otherwise healthy?

A pre-screening visit for a healthy, asymptomatic patient is not typically separately billable as it is part of routine preventive services and does not meet criteria for a separate E/M service.

What are some examples of screening colonoscopy coding?

The following are real-life examples of the application of colonoscopy screening coding in clinical and payer scenarios. These cases illustrate how to choose the appropriate CPT/HCPCS codes, diagnosis codes, and modifiers when the procedure is preventive or when a therapeutic procedure is performed.

What is the correct coding for a routine average-risk screening colonoscopy with normal findings?

In a standard screening scenario, an asymptomatic patient undergoes a colonoscopy and no abnormalities are detected. The procedure remains preventive in nature since it was initiated for colorectal cancer screening purposes.

• Medicare - G0121
• Commercial Insurance: 45378 + Modifier 33
• Diagnosis Code: V76.51

This reflects a straightforward preventive screening where full coverage may apply when coded correctly.

What is the correct coding for a high-risk screening colonoscopy with normal findings?

When a patient is classified as high risk due to medical or family history, screening frequency and coding differ even if no findings are present during the procedure.

• Medicare: G0105
• Commercial Insurance: 45378 + Modifier 33
• Diagnosis Code: V12.72

This scenario is driven by risk status rather than findings, which determines screening eligibility and billing classification.

What is the correct coding when polyps are removed during a screening colonoscopy?

If a patient falls into the "high risk" category because of medical or family history, the frequency of screening and coding may differ, even in the absence of findings at the time of the procedure.

• Procedure Code: 45385
• Modifiers: PT (Medicare) / 33 (Commercial)
• Diagnosis Codes: V76.51 + 211.3 (based on pathology)

This ensures the claim reflects both the screening intent and therapeutic intervention.

What is the correct coding when a biopsy is performed during a screening colonoscopy?

When polyps are found and removed during a screening exam, it is technically a therapeutic procedure, but has the screening origin.

• Procedure Code: 45380
• Modifiers: PT (Medicare) / 33 (Commercial)
• Diagnosis Codes: V12.72 + 211.4 / 235.2 (based on pathology)

This scenario requires documentation of both screening history and diagnostic findings.

What is the correct coding for a diagnostic colonoscopy due to symptoms?

If a patient presents with symptoms such as change in bowel habits or bleeding, the procedure is no longer considered screening, even if findings are normal.

• Procedure Code: 45378
• Modifiers: None (no PT or 33)
• Diagnosis Code: Symptom-based diagnosis

This will ensure that the screening purpose and therapeutic intervention are reflected in the claim. 

How to Report a Screening Colonoscopy Becoming Therapeutic?

If abnormalities are detected during a screening colonoscopy, like polyps, which are treated, the screening role will be changed to a treatment role. If this occurs, the correct coding should be used to accurately document the procedure performed and maintain the intent for the screening in order to receive proper reimbursement. 

How do you report a screening colonoscopy that becomes therapeutic?

When a screening colonoscopy results in the removal of one or more polyps or other therapeutic intervention, the procedure is reported using the appropriate CPT code for the service performed (e.g., 45379–45392 range). Although the intervention is therapeutic, the screening intent remains primary, and any findings (such as polyps) are considered secondary.

What modifiers are suppose to be used when a screening colonoscopy becomes therapeutic?

When a screening colonoscopy is converted into a diagnostic or therapeutic procedure, specific modifiers are required to correctly identify the service type and ensure proper claim processing based on payer rules.

Modifier PT was developed by CMS for use in Medicare to denote that a colonoscopy was performed as a screening procedure but was changed to a diagnostic or therapeutic procedure. This modifier is used with the CPT code on Medicare claims to ensure the correct screening related processing rules.

For commercial insurance plans, Modifier 33 is used to indicate that the service was initiated as a preventive screening under USPSTF guidelines, even if a therapeutic intervention such as polyp removal occurs during the procedure.

Polyp removal via snare after a screening colonoscopy, for instance, is reported as code 45385:

• Medicare: 45385 + Modifier PT
• Commercial insurance: 45385 + Modifier 33

Applying modifiers correctly categorizes the service, makes proper reimbursements, and applies preventive benefits correctly.

Is the diagnosis code order important in these cases?

Absolutely, the process of claims diagnosis is relevant to the claims process. The screening diagnosis should be included first followed by any diagnosis such as polyps or lesions. A claim may be misordered when it could impact claim adjudication or cost-sharing for the patient depending on the payers' rules. 

What if a biopsy or polypectomy is performed during a screening colonoscopy?

If a lesion is identified and a biopsy or removal is done, the colonoscopy should be billed based on the most definitive procedure performed (e.g. biopsey, 45380-45385 range, removal, etc.). Modifier 33 should be used for commercial claims and Modifier PT should be used for Medicare claims. When the procedure is coded correctly, the procedure is still coded as a screening encounter and it accurately represents the therapeutic service provided. 

How to Handle Complex Screening Colonoscopy Billing Scenarios?

In clinical practice, screening colonoscopy billing becomes more complex when patient comorbidities, procedural limitations, or repeat screening intervals affect coding decisions. In these cases, proper use of E/M codes, modifiers and Medicare frequency guidelines will help prevent denials and ensure proper reimbursement. 

Can you bill a visit if a patient on Coumadin is referred for a screening colonoscopy?

Yes. If a patient requires medical management before the procedure, such as anticoagulation adjustment for Coumadin, the visit becomes a billable New Patient or Established Patient E/M service, depending on whether the patient has been seen within the last three years by a provider of the same specialty in the practice.

How should a colonoscopy be coded if poor bowel preparation prevents full examination?

When a screening colonoscopy fails to be performed because of poor colonoscopy preparation and the colonoscope is not advanced beyond the splenic flexure, the procedure should not be coded as a flexible sigmoidoscopy. However, it should be reported instead as a colonoscopy with Modifier 53 (discontinued procedure). This provides partial reimbursement and enables one to bill the procedure again in accordance with Medicare guidelines. 

Will Medicare cover a diagnostic colonoscopy if a screening was performed two years ago?

Yes. Medicare frequency limitations apply only to repeat screening colonoscopies in asymptomatic patients. If a patient develops symptoms that justify a diagnostic colonoscopy, the procedure is considered medically necessary and is eligible for reimbursement. However, standard cost-sharing (co-pay, deductible, or coinsurance) will apply for the diagnostic service.

How is a repeat screening colonoscopy handled within restricted time intervals?

Receiving a screening colonoscopy less often than the insurance company allows (every 10 years for average risk and every 24 months for high risk) will also likely be deemed not medically necessary. In the event that the exam has been performed incompletely or it was not possible to visualize the splenic flexure, repeat procedure should be reported with Modifier 53, even if the scope went further, to indicate that the exam was partially or entirely discontinued. 

BillingFreedom Expertise in Gastroenterology Medical Billing And Coding Accuracy, Compliance, and Revenue Optimization

Colonoscopy billing is not simple. Screening vs. diagnostic classification, modifier selection, risk-based coding rules, and payer-specific requirements all run together in ways that create real exposure for practices that are not paying close attention. BillingFreedom manages that complexity directly.

BillingFreedom focuses on the Gastroenterology Medical Billing And Coding specially for screening and diagnostic colonoscopy billing and coding process, covering all Medicare guidelines, CPT/HCPCS coding rules, and payer-specific requirements. Our highly qualified staff is constantly updated on changing CMS policies such as modifier usage (33, PT, 53, KX), risk-based screening rules, preventive service billing policies and more to ensure accurate claim submission and maximum reimbursement integrity. 

Key Performance Metrics

• Coding Accuracy Rate at 98.8% – Provides accurate coding for colonoscopy codes, modifiers, and diagnosis sequencing.
• Claim Acceptance Rate: 97.5% – Obtained by having a structured claim review and validation of payers' rules
• Denial Rate: <1% – Proactively identified and checked for compliance
• Modifier Accuracy: 99%+ – Good control of critical modifiers such as 33, PT, 53 and KX 

Impact on Revenue Cycle

This high level of accuracy directly improves healthcare revenue by:

• Minimizing claim denials and re-submissions
• Ensuring correct classification of screening vs diagnostic procedures
• Avoiding lost and/or incorrect modifiers to the billable code
• Speeding up the reimbursement process by submitting clean claims 

To find out more information about our superior medical billing services, do not hesitate to write us an email at info@billingfreedom.com or call us at +1 (855) 415-3472. 

We are concerned about your financial peace!